Glucose variability in older adults with type 2 diabetes treated with continuous subcutaneous insulin infusion (CSII) and multiple daily injections of insulin (MDI)

被引:0
|
作者
Johnson, Susan L.
McEwen, Laura N.
Newton, Christopher A.
Martin, Catherine L.
Raskin, Philip H.
Herman, William H.
机构
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:A149 / A149
页数:1
相关论文
共 50 条
  • [1] The impact of continuous subcutaneous insulin infusion and multiple daily injections of insulin on glucose variability in older adults with type 2 diabetes
    Johnson, Susan L.
    McEwen, Laura N.
    Newton, Christopher A.
    Martin, Catherine L.
    Raskin, Philip
    Halter, Jeffrey B.
    Herman, William H.
    JOURNAL OF DIABETES AND ITS COMPLICATIONS, 2011, 25 (04) : 211 - 215
  • [2] Transitioning patients with type 1 diabetes from multiple daily injections (MDI) to continuous subcutaneous insulin infusion (CSII)
    Kumar, RP
    Hirsch, IB
    DIABETES, 2004, 53 : A110 - A110
  • [3] Glycemic Variability in Adults with Type 1 Diabetes Using Continuous Subcutaneous Insulin Infusion (CSII) Compared with Multiple Daily Injection (MDI) Treatment
    Scott, Emma
    Mcgrath, Rachel
    Januszewski, Andrzej S.
    Calandro, Daniel
    O'Neal, David
    Fulcher, Greg
    Jenkins, Alicia J.
    DIABETES, 2017, 66 : A278 - A279
  • [4] A clinical trial of continuous subcutaneous insulin infusion versus multiple daily injections in older adults with type 2 diabetes
    Harthi, AA
    Ilag, LL
    Johnson, SL
    Martin, CL
    Sinding, J
    LaPorte, FB
    Raskin, P
    Herman, WH
    DIABETOLOGIA, 2005, 48 : A308 - A308
  • [5] A clinical trial of continuous subcutaneous insulin infusion versus multiple daily injections in older adults with type 2 diabetes
    Herman, WH
    Ilag, LL
    Johnson, SL
    Martin, CL
    Sinding, J
    Al Harthi, A
    Plunkett, CD
    LaPorte, FB
    Burke, R
    Brown, MB
    Halter, JB
    Raskin, P
    DIABETES CARE, 2005, 28 (07) : 1568 - 1573
  • [6] Assessing depressive symptoms and diabetes distress in Type 1 diabetic adults: A comparison of continuous subcutaneous insulin infusion (CSII) and multiple daily injections (MDI) users
    Dowling, Ella
    Maidment, David W.
    JOURNAL OF HEALTH PSYCHOLOGY, 2023, 28 (02) : 149 - 161
  • [7] Continuous subcutaneous insulin infusion (CSII) versus multiple insulin injections for type 1 diabetes mellitus
    Misso, M. L.
    Egberts, K. J.
    Page, M.
    O'Connor, D.
    Shaw, J.
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2010, (01):
  • [8] Transition from multiple daily injections (MDI) to continuous subcutaneous insulin infusion (CSII): Characteristics of a pediatric population
    Conrad, SC
    McGrath, MT
    Adi, S
    Greenspan, LC
    Lee, J
    Rosenthal, SM
    Gitelman, SE
    DIABETES, 2000, 49 : A101 - A101
  • [9] Switch from continuous subcutaneous insulin infusion (CSII) with insulin lispro [Humalog®]to multiple daily injections (MDI) with insulin glargine (Lantus) and insulin lispro
    Bode, B
    Schleusener, D
    Strange, P
    DIABETES, 2003, 52 : A102 - A103
  • [10] Glycaemic variability in paediatric patients with type 1 diabetes on continuous subcutaneous insulin infusion (CSII) or multiple daily injections (MDI): a cross-sectional cohort study
    Schreiver, C.
    Jacoby, U.
    Watzer, B.
    Thomas, A.
    Haffner, D.
    Fischer, D. -C.
    CLINICAL ENDOCRINOLOGY, 2013, 79 (05) : 641 - 647